Canada approves first generic semaglutide injection for weight loss

FILE - A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File)

OTTAWA - Health Canada has approved a generic version of Wegovy, a semaglutide drug that's prescribed to help people lose weight.

The weekly injection is known as Svemia from the Canadian company Apotex and is pharmaceutically equivalent to weight-loss medication Wegovy from Denmark's Novo Nordisk.

¹ú²úÓÕ»ó¸£Àû

More National Stories

Sign Up to Newsletters

Get the latest from ¹ú²úÓÕ»ó¸£Àû News in your inbox. Select the emails you're interested in below.